default author photo

Ting Niu

Sichuan University

SCHOLARLY PAPERS

1

DOWNLOADS

61

TOTAL CITATIONS

0

Scholarly Papers (1)

Actions:
Email selected abstracts
1.

Targeted Agents Plus CHOP Compared with CHOP as the First-Line Treatment for Newly Diagnosed Patients with Peripheral T-Cell Lymphoma (GUIDANCE-03): An Open-Label, Multicentre Phase 2 Clinical Trial

Number of pages: 38 Posted: 27 Feb 2024
Ming-Ci Cai, Shu Cheng, Hongmei Jing, Yan Liu, Guohui Cui, Ting Niu, Jianzhen Shen, Liang Huang, Xin Wang, Yao-Hui Huang, Li Wang, Peng-peng Xu and Wei-Li Zhao
Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics, Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics, Peking University - Lymphoma Research Center, Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics, Huazhong University of Science and Technology - Institute of Hematology, Sichuan University, Fujian Medical University, affiliation not provided to SSRN, affiliation not provided to SSRN, Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics, Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics, Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics and Shanghai Jiao Tong University (SJTU) - State Key Laboratory of Medical Genomics
Downloads 61 (951,658)

Abstract:

Loading...

Peripheral T-cell lymphoma, decitabine, azacytidine, tucidinostat, lenalidomide, CHOP, complete response rate, prognosis